EMEA debuts faster advice procedure

A "New Framework for Scientific Advice and Protocol Assistance" has been finalized by the European Medicines Agency (EMEA). This introduces significant changes to the way that the Agency provides scientific advice on the R&D of new medicines.

The main aspects of the new framework include:

- earlier and greater systematic involvement of internal and external experts from the pre-submission phase to the final adoption of scientific advice;